SC 13D Filing

Company

ELITE PHARMACEUTICALS INC /NV/

Filed

March 6, 2009

Accession Number

0000947871-09-000157

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →